medroxyprogesterone acetate has been researched along with Viral Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barkley, MS; Kullolli, O; Logiodice, F; Lombardelli, L; Maggi, E; Piccinni, MP | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Viral Diseases
| Article | Year |
|---|---|
Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease.
Topics: Adult; Bacterial Infections; Basic Helix-Loop-Helix Transcription Factors; Cytokines; Disease Susceptibility; Female; Humans; Inflammation; Macrophages; Male; Medroxyprogesterone Acetate; Nuclear Receptor Subfamily 1, Group F, Member 3; Receptors, Aryl Hydrocarbon; Sex Factors; Signal Transduction; T-Box Domain Proteins; Th1 Cells; Th17 Cells; Virus Diseases | 2019 |
20 years, 20 articles: studies to know.
Topics: Acquired Immunodeficiency Syndrome; Americas; Breast Feeding; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Developed Countries; Disease; Family Planning Services; Health; HIV Infections; Infant Nutritional Physiological Phenomena; Intrauterine Devices; Lactation; Medroxyprogesterone Acetate; Neoplasms; North America; Nutritional Physiological Phenomena; Research; Sterilization, Reproductive; Sterilization, Tubal; United States; Virus Diseases | 2000 |